Presentation

P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanisms

Martin Friede

Plenary presentation

Authors

Languages

  • English

Publication year

2014

Type

Presentation

Categories

  • Global initiatives

GVIRF-2014

You can find more information about "GVIRF-2014" in the following Hot Topics:

TitleAuthorYearTypeLanguage
KN2 Research for Universal Health Coverage; Perspective on Vaccines and Poverty ReductionMargaret Chan, Tim Evans2000ReportEnglish
W8 Systems VaccinologyIngileif JonsdottirReportEnglish
W6 Innovation in vaccine delivery and presentation: How can technological advances increase program performance?M. Gottlieb, R. LagosReportEnglish
P7 Innovative vaccine research: the point of view of industry and biotech companiesMichael Mowatt, Odile LeroyReportEnglish
W7 Contributions of Regulatory Science to Vaccine AccessHelen Rees, Norman BaylorReportEnglish
KN3-1 The Importance of Innovation in Addressing Global Health Gaps in the Developing WorldTrevor MundelPresentationEnglish
KN3 Importance of Innovation in Addressing Global Health Gaps in the Developing WorldTrevor MundelReportEnglish
P6 Protection of pregnant women, neonates and infants by maternal immunizationHelen Rees2014ReportEnglish
P5 Research to improve monitoring and evaluation of immunization programsJean-Marie Okwo-Bele2014ReportEnglish
P3 Developing Next Generation Vaccines: Defining the Improvements Needed and Evaluating Their PotentialK. Neuzil2014ReportEnglish
P2 Regulatory and Public Health Challenges for Vaccines Inducing Modest EfficacyDavid Salisbury2014ReportEnglish
Agenda - GVIRF 2014GVIRF Secretariat2014PresentationEnglish
W8.3 Application of technological advances to clinical trialsWillem Hanekom2014PresentationEnglish
W8.2 Systems VaccinologyBali Pulendran2014PresentationEnglish
W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development?Ingileif Jonsdottir2014PresentationEnglish
W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines?Marion Gruber2014PresentationEnglish
W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New VaccinesTeeranart Jivapaisarnpong2014PresentationEnglish
W7.1 Contributions of Regulatory Science to Vaccine AccessNorman W. Baylor2014PresentationEnglish
W6.3 Case Study: The Uniject Injection SystemDebra Kristensen2014PresentationEnglish
W6.2 Beyond the cold chain… Meningitis A conjugate vaccine in a controlled temperature chain: Experience from BeninOlivier Ronveaux2014PresentationEnglish
W6.1 WHO - Next-generation Vaccine Delivery Technology Meeting SummaryDarin Zehrung2014PresentationEnglish
W5.4 Building Implementation Research Capacity for Polio EradicationMargaret Gyapong2014PresentationEnglish
W5.3 Strengthening national capacity for evidence-based immunization policy: the case of program costing in HondurasCara Bess Janusz2014PresentationEnglish
W5.2 Factors influencing community health volunteers in participating in health programs in AfricaFadima YAYA BOCOUM2014PresentationEnglish
W5.1 Immunization implementation research priority settingJohn Clemens2014PresentationEnglish
W4.2 Prioritizing the Research Agenda for Measles and RubellaWilliam Moss2014PresentationEnglish
W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella GoalsThomas Cherian2014PresentationEnglish
W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countriesD. Briggs2014PresentationEnglish
W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategiesFarrokh Modabber2014PresentationEnglish
W2.3 Group A streptococcal vaccines: Challenges and progressFlorian Schödel2014PresentationEnglish
W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and ProgressClaudio Lanata2014PresentationEnglish
W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public HealthVasee Moorthy2014PresentationEnglish
W1.1 Towards the Development of a Universal Influenza VaccineDavid Spiro2014PresentationEnglish
P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanismsMartin Friede2014PresentationEnglish
P6.2 Maternal Immunization: which impact on infant immunity?Claire-Anne Siegrist2014PresentationEnglish
P6.1 Public Health Benefits of Maternal ImmunizationKeith Klugman2014PresentationEnglish
P5.2 Influenza Vaccine Use in the Americas: Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-1Alba María Ropero-Álvarez2014PresentationEnglish
P5.1 Immunization Registries in Latin America and the CaribbeanM. Carolina Danovaro-Holliday2014PresentationEnglish
P3.4 Evaluation of the Next Generation of Rotavirus VaccinesKathleen Neuzil2014PresentationEnglish
P3.3 Developing Next Generation Rotavirus Vaccines: Prospects from the Pipeline to Address Remaining Public Health NeedsMary K. Estes2014PresentationEnglish
P3.2 Developing Country Vaccine Manufacturers - Access to ImmunizationUmesh Parashar2014PresentationEnglish
P3.1 Developing next generation vaccines: IntroductionKathleen Neuzil2014PresentationEnglish
P2.2 Regulatory Considerations for Determining Vaccine EfficacyMarion Gruber2014PresentationEnglish
P2.1 Regulatory and public health challengesPeter Smith2014PresentationEnglish
P1c.2 Progress towards the development of a malaria vaccine: discussionPeter Smith2014PresentationEnglish
P1c.1 Progress towards the development of a malaria vaccineAshley Birkett2014PresentationEnglish
P1b.2 TB Vaccine Development: Challenges & OpportunitiesUli Fruth2014PresentationEnglish
P1b.1 Update on Tuberculosis Vaccines - 2014Tom Evans2014PresentationEnglish
P1a.2 Progress towards the development of an HIV vaccine: DiscussionJosé Esparza2014PresentationEnglish
P1a.1 Status of HIV Vaccine Research & DevelopmentWayne Koff2014PresentationEnglish

Added by: Angela Hwang

Added on: 2022-08-07 02:36:10

Hits: 1453

Uploaded file

P7-1Friede.pdf

Click to Download

Add resource